Please assess the completion status of the following clinical trial:

Trial Title: A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Insomnia as defined by DSM-IV criteria and supported by subject diary~* Male or female between the ages of 18-64 years~* Body mass index (BMI) between 18-34 kg/m\^2~* Females of childbearing potential must use a medically acceptable method of contraception~* Capable of understanding and willing to comply with study procedures and has provided informed consent~Exclusion Criteria:~* Females who are pregnant, breast-feeding or have a positive pregnancy test~* Any circadian rhythm disorder including planned travel across several time zones during the study period~* Known hypersensitivity to Zolpidem~* Has performed regular shift work with the past several months prior to screening~* An acute clinically significant illness or surgery as determined by the PI within 30 days of screening~* Patients that have used any central nervous system (CNS) medication or other medication known to impact the sleep/wake cycle~* A history of psychiatric disorder as defined by DSM-IV~* A history of drug addiction or alcohol abuse~* Any current significant disease, unless adequately controlled with a protocol allowed medication~* Known history of HIV or Hepatitis B or C~* Patients who have received an investigational drug within several months of screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- placebo/zolpidem 3.5/zolpidem 1.75 (Type: EXPERIMENTAL): None
- placebo/zolpidem 1.75/zolpidem 3.5 (Type: EXPERIMENTAL): None
- zolpidem 3.5/placebo/zolpidem 1.75 (Type: EXPERIMENTAL): None
- zolpidem 3.5/zolpidem 1.75/placebo (Type: EXPERIMENTAL): None
- zolpidem 1.75/placebo/zolpidem 3.5 (Type: EXPERIMENTAL): None
- zolpidem 1.75/zolpidem 3.5/placebo (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).